🇺🇸 FDA
Patent

US 11771737

Treating or preventing adverse liver conditions

granted A61KA61K2039/505A61K31/4985

Quick answer

US patent 11771737 (Treating or preventing adverse liver conditions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K31/4985, A61K31/575, A61K38/14